does semaglutide make you eat less 🥇 What to and What to Avoid When Taking for Weight Loss: A Guide Common And Rare Side Effects

10.1007/s00429-016-1196-y Brain Struct Funct

The approvals of Wegovy (2021) and tirzepatide (Mounjaro, 2022

Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use

In this article: What causes skin purging

GLP-1 programs that are provided by physicians via telehealth indicate the increasing need in medically-monitored weight-loss programs

(L-Carnitine)?